House panel calls to ban China trial data from FDA drug trial applicationsnews2026-04-30T18:28:13+00:00April 30th, 2026|Endpoints News|
MPM has collected three China drugs for its ‘best of both worlds’ strategynews2026-04-29T11:00:19+00:00April 29th, 2026|Endpoints News|
FDA debuts plan to collect real-time clinical trial datanews2026-04-28T18:19:33+00:00April 28th, 2026|Endpoints News|
Revolution Medicines threatens to sue Erasca over patent, efficacy claimsnews2026-04-27T18:17:42+00:00April 27th, 2026|Endpoints News|
RFK Jr. says China is ‘eating our lunch’ in biotech advancesnews2026-04-21T18:45:47+00:00April 21st, 2026|Endpoints News|
China dominates big licensing deals as M&A starts 2026 with a bangnews2026-04-15T13:00:51+00:00April 15th, 2026|Endpoints News|
China biotech’s CRISPR therapy suggests US drugmakers will face competitionnews2026-04-10T15:54:15+00:00April 10th, 2026|Endpoints News|
China-based CAR-T company Oricell raises $40M more as it looks to go publicnews2026-04-10T10:28:17+00:00April 10th, 2026|Endpoints News|
China-based AI biotech Ailux hires CSO, eyes clinic in 2027news2026-04-09T14:00:15+00:00April 9th, 2026|Endpoints News|
Proposed FDA budget sets Makary up to boost US biotechnews2026-04-06T18:38:19+00:00April 6th, 2026|Endpoints News|
